Robert Nelsen, 10% Owner at Neumora Therapeutics, Inc. (NMRA), bought 153,022 shares at $13.06 ($2.1M) on 2023-09-28, disclosed to the SEC on 2023-09-29.
Open-market purchase of $2.1M NMRA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.06 | 16,841 | $220K | 10.5% |
| 2 | $13.06 | 16,841 | $220K | 10.5% |
| 3 | $13.69 | 25,110 | $344K | 16.4% |
| 4 | $13.69 | 25,110 | $344K | 16.4% |
| 5 | $13.98 | 34,560 | $483K | 23.1% |
| 6 | $13.98 | 34,560 |
| $483K |
| 23.1% |
| Total | $13.68 avg | 153,022 | $2.1M | 100% |
| Filing → |
| SANA | BUY | 2024-02-12 | $8.0M | — | Filing → |
| NMRA | BUY | 2023-09-27 | $1.0M | — | Filing → |
| NMRA | BUY | 2023-09-25 | $1.8M | — | Filing → |